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Cysteine-containing leukotrienes (cysteinyl-LTs) are potent bron-
choconstrictors and play a key role in asthma. We found that his-
 
tamine and LTD
 
4
 
 markedly constrict strips of human bronchi (HB)
with similar efficacy. However, in human airway smooth-muscle
(HASM) cells, LTD
 
4
 
, at variance with histamine, elicited only a
small, transient change in intracellular calcium ion concentration.
HASM cells express both Ca
 
2
 
1
 
-dependent and -independent iso-
forms of protein kinase C (PKC) (i.e., PKC-
 
a
 
 and PKC-
 
«
 
). Western
blot analysis showed that PKC-
 
a
 
 is activated by histamine and, to
a lesser extent, by LTD
 
4
 
, whereas only LTD
 
4
 
 translocates PKC-
 
«
 
.
This translocation was specifically inhibited by the LTD
 
4
 
 antago-
nist pobilukast. Phorbol-dibutyrate ester (PDBu) (a PKC activator)
contracted HB strips to the same extent in the presence as in the
absence of extra- and intracellular Ca
 
2
 
1
 
. In the absence of Ca
 
2
 
1
 
,
LTD
 
4
 
 contracted HB strips to the same extent as did PDBu, sug-
gesting the involvement of a Ca
 
2
 
1
 
-independent PKC in LTD
 
4
 
-medi-
ated signal transduction. PDBu-induced desensitization and the
PKC inhibitor H7 abolished the slow and sustained LTD
 
4
 
-triggered
contraction of HB strips in the absence of Ca
 
2
 
1
 
, although H7 did
not greatly affect the response in the presence of the ion. Thus, in
human airways, we identified a novel LTD
 
4
 
 transduction mecha-
nism linked to bronchial smooth-muscle contraction, which is
partly independent of Ca
 
2
 
1
 
 and involves the activation of PKC-
 
«
 
.
 
Cysteine-containing leukotrienes (cysteinyl-LTs) are pivotal in-
flammatory mediators formed through the 5-lipoxygenase path-
way of arachidonic acid (1), and may contribute to the patho-
genesis of asthma (2–4). In particular, cysteinyl-LTs are very
potent constrictors of human bronchi (HB) not only 
 
in vitro
 
 (5),
but also 
 
in vivo
 
, in both normal and asthmatic individuals (6).
Among the cysteinyl-LTs, LTD
 
4
 
 has been studied most ex-
tensively, and is known to act through specific G-protein–cou-
pled receptors (7, 8), inducing phosphoinositol hydrolysis (9,
10) and an increase in the cytosolic Ca
 
2
 
1
 
 concentration (intra-
cellular [Ca
 
2
 
1
 
]; [Ca
 
2
 
1
 
]
 
i
 
) (11–13). The latter effect in particular
occurs in tracheal smooth-muscle cells (14).
Differences exist between cell types with respect both to
the role of Ca
 
2
 
1
 
 and to the mechanisms of the LTD
 
4
 
-induced
increase in [Ca
 
2
 
1
 
]
 
i
 
 (15). For instance, LTD
 
4
 
 can induce either
Ca
 
2
 
1
 
 influx through the plasma membrane without any Ca
 
2
 
1
 
release from intracellular stores (11, 12), or Ca
 
2
 
1
 
 release with-
out influx (16), and, in many cell types can induce both Ca
 
2
 
1
 
influx and release (9, 13, 14).
The role of Ca
 
2
 
1
 
 in muscle contraction has been investi-
gated for many years: Ca
 
2
 
1
 
-dependent phosphorylation of
myosin light chain is a major pathway for the regulation of
smooth-muscle contractile force (17). However, the force/
Ca
 
2
 
1
 
 ratio is variable (18), and the mechanism of action of ag-
onist-induced smooth-muscle contraction (pharmacomechani-
cal coupling) may consist of an alteration of the sensitivity of
the contractile apparatus to Ca
 
2
 
1
 
 (19). In some instances, ago-
nist-triggered contraction can occur with little or no change in
[Ca
 
2
 
1
 
]
 
i
 
 (17, 20). In airway smooth muscle (ASM), including
that of the human bronchus, the Ca
 
2
 
1
 
-sensitivity of the con-
tractile apparatus is very high and displays high positive coop-
erativity (21); quite often, the tonic activation of ASM by a
 
variety of agonists depends on Ca
 
2
 
1
 
 influx from the extracel-
lular space (22, 23). However, despite the existence of volt-
age-operated calcium channels (VOC) in human airways (24),
Ca
 
2
 
1
 
-entry blockers are relatively ineffective in inhibiting
bronchoconstriction in asthma, indicating that airway narrow-
ing in asthma is mediated mainly by other means than VOCs.
Accordingly, it has recently been suggested (25) that LTD
 
4
 
contracts human bronchi through a receptor-operated Ca
 
2
 
1
 
channel (ROC).
The aim of the present study was to clarify whether varia-
tions in [Ca
 
2
 
1
 
]
 
i
 
 play a major role in LTD
 
4
 
-induced contraction
of HB, or whether other signal-transduction mechanisms are
involved. For this purpose, we compared the 
 
in vitro
 
 contrac-
tion of isolated HB with increases in [Ca
 
2
 
1
 
]
 
i
 
 and protein ki-
nase C (PKC) activation in isolated smooth-muscle cells ob-
tained from the same tissue.
 
METHODS
 
All experiments were performed in the presence of 10 mM cysteine to
prevent metabolism of LTD
 
4
 
 (26).
 
Cell Isolation Procedure
 
Smooth-muscle cells from HB were isolated as previously described
(27). Briefly, macroscopically normal fragments of lung were obtained
at thoracotomy. Third-order bronchi were removed, under sterile
conditions, the connective tissue and the epithelium were removed,
 
and the smooth muscle was cut into pieces weighing approximately
10 mg each. The explants were grown at 37
 
8
 
 C in a humidified atmo-
sphere of 5% CO
 
2
 
 in Medium 199, with the addition of 20% (vol/vol)
fetal calf serum (FCS), 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomy-
cin. Cells were grown in monolayers in minimum essential medium
(MEM) supplemented with 10% FCS, 100 U/ml penicillin, and 100
 
m
 
g/ml streptomycin, and were used between passages 3 and 8. The
cells stained positively with an antibody to smooth-muscle 
 
a
 
-actin.
 
Measurements of [Ca
 
2
 
1
 
]
 
i
 
Human bronchial cells were seeded onto coverslips and used when
they reached 100% confluence. The cells were incubated for 45 min at
30
 
8
 
 C in the dark, with 5 
 
m
 
M Fluo3 acetoxymethyl ester (Fluo3/AM)
 
(28) in MEM plus 0.03% Pluronic F-127, 2.5 mM probenecid, and
10 mM 4-(2-hydroxyethyl)-1-piperazine-
 
N
 
9
 
-2-ethanesulfonic acid
(HEPES). After loading, cells were washed twice with saline solution
 
(NaCl 145 mM, KCl 5 mM, MgCl
 
2
 
 1 mM, CaCl
 
2
 
 1.8 mM, HEPES 10 mM,
 
(
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glucose 10 mM; pH 7.4) plus 2.5 mM probenecid, and were kept at
room temperature for 15 min to complete hydrolysis of the Fluo3/AM.
The coverslips were then transferred to a spectrofluorometer (Perkin
Elmer LS5; Perkin Elmer Italia, Monza, Italy) cuvette, and the fluo-
rescence of the cell preparations was monitored at 30
 
8
 
 C (506-nm exci-
tation, 530-nm emission). In order to evaluate [Ca
 
2
 
1
 
]
 
i
 
 from fluorescence
readings, F
 
max
 
 (maximal fluorescence of the system) was obtained by
adding 2.7 
 
m
 
M ionomycin and 100 
 
m
 
M digitonin and F
 
min
 
 was ob-
tained by measuring the autofluorescence of cells that were not ex-
posed to Fluo3/AM (29). [Ca
 
2
 
1
 
]
 
i
 
 was determined according to the
method of Tsien and colleagues (30), with 
 
K
 
d
 
 
 
5
 
 646 nM, which was
calculated by assuming a linear dependence on temperature (29). In-
creases in [Ca
 
2
 
1
 
]
 
i
 
 were expressed as the ratio of the stimulated over
the basal level (s/b).
 
Preparation of Isolated HB
 
Macroscopically normal HB (2- to 3-mm diameter) were obtained from
patients undergoing thoracic surgery for pulmonary carcinoma, and
were prepared as previously described (31). Briefly, the bronchi were
dissected free of parenchyma and blood vessels, and were cut helically
into strips 2 to 3 mm wide and about 10 mm long. The strips were sus-
pended in organ baths containing Tyrode’s solution (composition in
mM: NaCl, 140; KCl, 3; CaCl
 
2
 
, 1; MgCl
 
2
 
, 0.05; NaH
 
2
 
PO
 
4
 
, 0.5; glucose,
8.4; NaHCO
 
3
 
, 12; pH 7.4) at 37
 
8
 
 C, which was bubbled with 95% O
 
2
 
–
5% CO
 
2
 
. Contractions were measured with a Basile 7004 isometric
force transducer (Ugo Basile, Comerio, Italy) and recorded on a Basile
Gemini 7070 polygraph. Bronchial strips were set at an initial tension of
1 g and repeatedly washed over a 60-min equilibration period. Contrac-
tions are expressed as the percent of the contraction induced by 300 
 
m
 
M
acetylcholine (ACh). When necessary, the Tyrode’s solution was re-
placed after ACh administration, with a solution lacking Ca
 
2
 
1
 
 and con-
taining 1 mM ethylene glycol-
 
bis
 
-(
 
b
 
-aminoethyl ether)-
 
N
 
,
 
N
 
,
 
N
 
9
 
,
 
N
 
9
 
-tet-
raacetic acid (EGTA) and 1 
 
m
 
M thapsigargin to eliminate intra- and
extracellular calcium. At the end of experiments with calcium- depleted
strips, contractility was verified by addition of 30 mM BaCl
 
2
 
.
 
Cell Contraction
 
Cells were grown in monolayers in Petri dishes as described earlier,
and were used at submaximal (95%) confluence. Cell contraction was
recorded by measuring the increase in intercellular spaces by means
of a TV camera connected to an inverted light microscope (Axiovert;
 
3
 
20 lens; Zeiss, Jena, Germany) coupled to an image analyzer (a
Macintosh computer [Apple Computer, Inc., Cupertino, CA] running
NIH Image v.1.62, developed by Dr. Wayne Rasband, of the National
Institutes of Health, Bethesda, MD) through a Data Translation Inc.
(Marlboro, MA) QuickCapture frame grabber card. Images were col-
lected for 15 min (one frame every 30 s). After 5 min of recording of
the control state, either histamine or LTD
 
4
 
 was added. When neces-
sary, intra- and extracellular Ca
 
2
 
1
 
 was removed as described earlier.
Image intensity is reported on a scale of 255 Gray Units with 0 for
white and 255 for black. The background intensity level (empty Petri
dishes) was determined to be in the range of 0 to 50 of Gray Units,
and all Gray-level readings of 50 or lower were converted to a red
color to represent intercellular spaces and to compute the percent in-
crease in intensity over the basal state.
 
Laser Scanning Confocal Fluorescence Microscopy
 
Cells were grown in monolayers on chamber slides and loaded with
Fluo3/AM as described earlier. The chamber slide was placed on a ther-
mostatically controlled copper plate (at 30
 
8
 
 C) on the stage of a confo-
cal microscope (MRC-600; Bio-Rad, Microsciences Division, Hemel
Hempstead, UK) coupled to an upright epifluorescence microscope
(Optiphot-2; Nikon, Tokyo, Japan). The indicated concentrations of
histamine or LTD
 
4
 
 were added to the cells with a microsyringe. Intrac-
ellular Fluo3 fluorescence in single living cells was measured by confo-
cal microscopy. Argon ion laser excitation was used at 488 nm, and the
power of the laser was kept at low values (
 
, 
 
0.1 mW) to preserve cell
viability and to avoid possible saturation of the fluorescence signal. Flu-
orescence emission was detected in the photon-counting mode with a
photomultiplier (S20 Thorn-EMI-9890; Bio-Rad Microsciences Divi-
sion, Hemel, Hempstead, UK) through a long pass filter at wavelengths
above 515 nm. The indicator fluorescence was followed in a field of
 
view of about 400 
 
3
 
 300 
 
m
 
2
 
, in which about 10 cells were inspected at
the same time through a 
 
3
 
20 air objective. The scan speed of the laser
excitation was set to 0.25 s for a frame of 384 
 
3
 
 256 pixels. Under these
conditions, a single scan of the field of view enabled us to obtain an ex-
cellent fluorescence image at a confocal aperture of about 2 mm and a
numerical aperture of 0.4. A temporal resolution of 2 s was used. The
time course of the indicator fluorescence was followed by using the time
series option of the MRC-600 COMOS software.
Image fluorescence intensities were recorded on a scale of 256
Gray Units (from 0 for black to 255 for peak white). False colors were
assigned to four ranges of Gray-Unit values, corresponding to four
ranges of Ca
 
2
 
1
 
 concentrations, as shown in Figure 7. The time depen-
dences of fluorescence intensities were studied in selected areas inside
single cells (about 40 to 80 
 
m
 
2
 
 wide), in which the mean Ca
 
2
 
1
 
 concen-
trations were evaluated.
 
Evaluation of PKC Translocation
 
Smooth-muscle cells were incubated for 18 h in culture medium with-
out FCS, and were then treated with the agents being investigated at
37
 
8
 
 C for 5 min, unless otherwise indicated. The incubation was stopped
at 4
 
8
 
 C and the cells were washed twice in cold phosphate-buffered sa-
line (PBS). Cells were then lysed at 4
 
8
 
 C for 30 min in 20 mM Tris-HCl,
pH 7.4, containing 2 mM EGTA, 20 mM ethylenediamine tetraacetic
acid (EDTA), 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM
dithiothreitol (DTT), and a set of protease inhibitors (Complete; Boeh-
ringer Mannheim, Mannheim, Germany). The lysed suspension was
centrifuged at 100,000 
 
3
 
 
 
g for 60 min, with the supernatant compris-
ing the cytosolic fraction. The pellet was resuspended in lysis buffer
plus 0.1% Triton X-110 at 48 C for 45 min, and centrifugation was then
repeated, with the resulting supernatants representing the membrane
fraction. The proteins in the cytosolic and membrane fractions were
separated by sodium dodecylsulfate–polyacrylamide gel electrophore-
sis (running gel: acrylamide 11%), and were electroblotted onto nitro-
cellulose paper. PKC isozymes were evaluated by Western blot analy-
sis, utilizing polyclonal antibodies raised against PKC-a (at a dilution
of 1:1,500) and PKC-« (at a dilution of 1:1,000) for 1 h at 258 C. After
washing with Tris-buffered saline (TBS) containing 0.1% Tween-20,
the sheets were incubated (1 h, 258 C) with peroxidase-conjugated an-
tirabbit IgG (1:3,000) and washed as described previously. Antigen–
antibody complexes were detected by enhanced chemiluminescence.
Results were analyzed with a computer-assisted image analysis pro-
gram (NIH Image v.1.62), and were expressed as percents of PKC
translocation versus basal conditions.
Statistical Analysis
Statistical analysis of the concentration–response curves for [Ca21]i
versus histamine or LTD4 was done with the ALLFIT computer pro-
gram (32), which calculates lower and upper plateaus, slope, and EC50
values, and allows the comparison of two or more curves. Selection of
the best fitting model and evaluation of the statistical significance of
parameter differences was based on the F test for the extra-sum-of-
squares principle (33). All curves shown in the illustrations were com-
puter generated.
Statistical comparison of multiple groups was done through one-
way analysis of variance followed by Bonferroni’s post hoc test. A sta-
tistical level of significance of p , 0.05 was accepted. Data are ex-
pressed as mean 6 SE. Each experiment was performed at least three
times and, when possible, in triplicate.
Materials
TBS, PBS, Hanks’ balanced salt solution (HBSS), Medium 199, Ea-
gle’s MEM, trypsin-EDTA, EGTA, penicillin (10,000 U/ml), strepto-
mycin (10 mg/ml), L-glutamine (200 mM), H7, dimethylsulfoxide, ACh,
histamine, probenecid, atropine, pyrilamine, L-cysteine, thapsigargin,
phorbol-dibutyrate ester (PDBu), anti–smooth-muscle a-actin anti-
body, peroxidase-conjugated antirabbit IgG, PMSF, and DTT were
from Sigma Chemical Co., St. Louis, MO. Antibodies to the PKC-a
and PKC-« isoforms, were from Boheringer Mannheim. LTD4 was
from Cayman Chemical Co., Ann Arbor, MI. All salts for Tyrode’s
solution were from Merck, Darmstadt, Germany. FCS was from PBI
International, Milan, Italy. Disposable culture flasks, Petri dishes, and
filters were from Corning Glassworks, Corning, NY. Fluo3/AM and
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pluronic F-127 were purchased from Molecular Probes, Eugene, OR.
MK 571 was a generous gift from Dr. A. W. Ford-Hutchinson of
Merck Frosst, Point Dorval, PQ, Canada, and SKF 104353 was kindly
provided by Dr. A. von Sprecher of the Research Department, Phar-
maceutical Division, Novartis Ltd., Basel, Switzerland.
RESULTS
Contraction of Human Airway Smooth-Muscle
Cells and of Isolated Strips of HB
Contraction of human airway smooth-muscle (HASM) cells in
monolayers was recorded by measuring the increase in inter-
cellular spaces by means of an image analyzer coupled to a
light microscope. LTD4 was able to contract HASM cells to
the same extent in the presence of Ca21 (30 6 8% [mean 6
SE] increase in intercellular spaces, n 5 6; Figures 1A and 1B)
as in its absence (which was effected by pretreatment with
1 mM EGTA and 300 nM thapsigargin, to eliminate extra-
and intracellular Ca21, respectively) (28 6 3%, n 5 3, data not
shown). The time-course of the increase in intercellular space
in the same field is shown in Figure 1C. On the contrary, the
effect of histamine, albeit generally greater than that of LTD4
(66 6 9%, n 5 6; Figures 1D and 1E), was greatly decreased
by the absence of Ca21 (26 6 9%, n 5 3, data not shown). Fig-
ure 1F shows the time course of the effect of histamine. The
concentration of thapsigargin used and the preincubation time
were sufficient to deplete the sensitive cytoplasmic stores of
Ca21 as assessed by [Ca21]i measurement (data not shown).
Both LTD4 (Figure 2A) and histamine (Figure 2B) caused
marked concentration-dependent bronchoconstriction with com-
parable efficacy in isolated strips of HB. The calculated EC50
values for LTD4 and histamine are summarized in Table 1.
[Ca21]i Increase in a Population of HASM
Cells and in Single HASM Cells
In a population of HASM cells, LTD4 (Figure 2C) was able to
elicit only a very modest, if any, transient increase in [Ca21]i
(maximum [Ca21]i increase: s/b 5 1.8 6 0.35). On the con-
trary, the response to histamine (Figure 2D) was concentra-
tion-dependent (EC50 5 30 mM), with a marked increase in
[Ca21]i (maximum increase: s/b 5 8.9 6 0.89). Representative
traces showing the [Ca21]i increases evoked by 1 mM LTD4
Figure 1. Light microscopic images of HASM cells made with a false-color map. Cell images are given in a scale of 256 Gray-Unit levels (from 0 for
white to 255 for black); of red color (0 to 50 Gray-Unit levels) represents intercellular spaces. Cells were used at submaximal (95%) confluence. (A)
Control cells. (B) Same field as in A after stimulation with 0.3 mM LTD4 (8 min). (C) Time-course of the percent increase in intercellular spaces in-
duced by LTD4 (data from A and B); frames were recorded at 30-s intervals. (D) Control cells. (E) Same field as in D after stimulation with 100 mM
histamine (5 min). (F) Time-course of the percent increase in intercellular spaces induced by histamine (data from D and E); frames were recorded
at 30-s intervals. The experiments were performed in the presence of 1 mM extracellular Ca21.
Figure 2. Concentration–response curves of agonist-induced contrac-
tion (A and B) of isolated human bronchi, and [Ca21]i increase (C and
D) in HASM cells. (A and C) LTD4. (B and D) Histamine. Insets in C and
D are representative tracings of the individual effect of agonist concen-
trations in inducing [Ca21]i increases. Curves in A and B were con-
structed with strips from seven different lung specimens. Curves in C
and D were obtained from four to seven experiments on cells obtained
from three to five different lung specimens, respectively.
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and 30 mM histamine, respectively, are shown as insets in Fig-
ures 2C and 2D. The response was completely abolished by
5 min of preincubation with specific antagonists (i.e., 1 mM
MK 571 and 30 mM mepyramine) (data not shown).
[Ca21]i transients in single HASM cells loaded with Fluo3
were studied with confocal fluorescence microscopy. Figure 3
shows the false-color images of cells under basal conditions
(Figure 3A) and at 40 s (Figure 3B), corresponding to the
peak [Ca21]i value, after stimulation with 100 mM histamine.
Figures 3C and 3D (48 s) show the results obtained with 1 mM
LTD4. Figures 4A and 4B show the mean [Ca
21]i increase in
response to histamine and LTD4, respectively, as a function of
time, measured in the cells indicated in Figure 3, as well as the
effect elicited by the vehicle alone (0.1% EtOH; Figure 3C). It
is clear that the effect of LTD4 was not much greater than that
of the appropriate control, whereas histamine elicited a much
greater increase in [Ca21]i. Furthermore, the specific antago-
nist SKF 104353 (10 mM) decreased the LTD4 response by only
a slight degree (data not shown).
Role of PKC in Contraction
Figures 5A through 5D show the contraction tracings for iso-
lated strips of HB prepared from adjacent segments chal-
lenged with LTD4 (0.3 mM). Compound H7 (50 mM), an inhib-
itor of PKC, did not affect LTD4-induced contraction in the
presence of Ca21 (Figure 5B), whereas in the absence of Ca21
it abolished the residual contraction usually present (compare
Figures 5C and 5D). Moreover, in the absence of Ca21, re-
peated in vitro administration of the PKC activator PDBu
(1 mM) completely inhibited LTD4-induced contraction of bron-
chial strips (Figure 5E).
When the strips were stimulated with 0.3 mM LTD4, the re-
moval of extra- and intracellular Ca21 markedly decreased,
but did not abolish, the contraction (Figures 6 and 5C). On the
contrary, the effect of PDBu, which induced a slowly develop-
ing contraction (Figure 5E), was not affected by removal of
Ca21 (Figure 6). In the case of histamine, no contraction was
detectable in the absence of Ca21 (data not shown).
Translocation of Different Isoforms of PKC
Figure 7 shows a representative Western blot analysis per-
formed with polyclonal antibodies to PKC-a, a calcium-depen-
dent isoform of PKC, and to PKC-«, a calcium-independent
isoform of the enzyme, on membrane proteins of HASM cells
incubated with either LTD4 or histamine. LTD4 at 0.3 mM in-
duced marked activation of the calcium-independent PKC-«
(170 6 15%; Figure 7B) and, to a lesser extent, of the calcium-
dependent PKC-a isoform (116 6 17%; Figure 7A), whereas
incubation with 100 mM histamine produced marked translo-
cation only of the calcium-dependent PKC-a isoform (514 6
181%; Figure 7A). The effect of LTD4 on PKC-« was time-depen-
dent, being maximal after 5 min of incubation and progres-
sively decreasing at 15 and 30 min (Figure 7C), thus suggesting
Figure 3. False-color confocal fluorescence microscopic images of HASM
cells loaded with the fluorescent Ca21 probe Fluo3. (A) Resting cells.
(B) Appearance at 40 s after the addition of 100 mM histamine. (C)
Resting cells. (D) Appearance at 48 s after the addition of 1 mM LTD4.
Fluorescence intensities were recorded on a scale of 256 Gray-Unit lev-
els and divided into four ranges, corresponding to four ranges of [Ca21]i
concentrations, to which pseudocolors were assigned. Images shown
are representative of seven or eight other experiments (for LTD4 and
histamine, respectively) on cells obtained from three to five different
lung specimens.
Figure 4. Mean [Ca21]i as a function of time with (A) 100 mM hista-
mine and (B) 1 mM LTD4. Measurements were made in the cells indi-
cated in Figure 3. (C) Effect of vehicle (0.1% EtOH) for LTD4 alone.
TABLE 1
POTENCY OF HISTAMINE AND LTD4 IN INDUCING CONTRACTION
OF HUMAN BRONCHIAL STRIPS AND Ca21 INCREASE IN CELLS
Agonist
Contraction [Ca21]i Increase
EC50
CV
(%) EC50
CV
(%)
Histamine 3.7 mM 11 30 mM 29
LTD4 1.6 nM 5 ND ND
Definition of abbreviations: [Ca21]i 5 intracellular calcium-ion concentration; CV 5
coefficient of variation; EC50 5 effective concentration causing 50% of maximal effect;
LTD4 5 leukotriene D4; ND 5 not determined.
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that prolonged incubation induces downregulation of this iso-
form of the kinase. Figure 7D shows a Western blot analysis of
membrane proteins of cells incubated with increasing concen-
trations of LTD4. LTD4 (5 nM and 0.3 mM) increased the
translocation of PKC-« by 143% 6 21 and 105 6 16, respec-
tively. In addition, 10 mM of SKF 104353 was able to counter-
act the effect of the highest concentration of LTD4.
As expected, removal of Ca21 abolished LTD4-induced trans-
location of PKC-a, but it did not affect the translocation of
PKC-« (Figure 8).
DISCUSSION
LTD4 is a potent constrictor of smooth muscle, including
bronchial smooth muscle. In most tissues and cells, this effect
has been shown to be receptor-mediated and coupled to an in-
crease in [Ca21]i (7, 15). Smooth-muscle contraction has been
directly correlated with either an increase in [Ca21]i (in the
guinea pig ileal longitudinal muscle [12]) or with an increased
hydrolysis of phosphatydyl inositol in lung [8]). On the con-
trary, we found that a discrepancy exists between contraction
and increased [Ca21]i in bronchial tissue. In fact, LTD4 was
able to contract strips of human bronchus in vitro to an extent
comparable with that elicited by histamine, albeit with much
higher potency, but was much less efficient in inducing an in-
crease in [Ca21]i in isolated smooth-muscle cells obtained from
the same organ.
One possible explanation for this discrepancy would be the
loss during cell isolation and culture of the LTD4 receptor that
was responsible for contraction. However, this hypothesis can
be ruled out, because the cultured cells actually responded to
LTD4 with measurable contractions that were inhibited by
MK-571, a specific LTD4 receptor antagonist. Another possi-
ble explanation would be a heterogeneity in the [Ca21]i re-
sponse in the cell population examined, with the cells either
not being synchronized in their Ca21 response or with few
cells expressing the receptor and therefore responding with an
increase in [Ca21]i. Laser scanning confocal fluorescence mi-
croscopy allowed us to measure [Ca21]i variations in single
HASM cells, and demonstrated that the percentage of cells re-
sponding to LTD4 with increases in [Ca
21]i was not lower than
that responding to histamine. Furthermore, the time-course of
Ca21 variation in response to LTD4 did not vary significantly
from cell to cell. The data obtained at the single-cell level
therefore confirmed those obtained in the overall cell popula-
tion, showing a marked difference in the peak [Ca21]i level
with histamine as opposed to LTD4, and excluding a heteroge-
neous cell response as the cause of the discrepant effect of
LTD4.
Thus, our data demonstrate a dissociation between LTD4-
induced contraction and increased [Ca21]i elevation and sug-
gest that Ca21-independent mechanisms contribute to LTD4-
triggered bronchoconstriction in human airways. Indeed, mea-
Figure 5. Representative tracings of contraction of isolated strips
of HB in response to 0.3 mM LTD4. (A and B) Tracings in the pres-
ence of Ca21 in the absence (A) and in the presence (B) of 50 mM
H7. (C through E) Tracings in the absence of Ca21 in the absence
(C) and in the presence (D) of 50 mM H7. (E) Tracing made after
repeated administration of 1 mM PDBu. The tracings are represen-
tative of two or three other tracings.
Figure 6. Contraction of isolated strips of HB in the presence or ab-
sence of intracellular and extracellular Ca21. Bars represent the mean 6
SE. Closed bars: LTD4 at 0.3 mM; hatched bars: PDBu at 1 mM. *p ,
0.05 versus addition of Ca21 (one-way analysis of variance, n 5 4).
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surement of single-cell contraction by light microscopy shows
that the removal of extra- and intracellular Ca21 elicits only a
minor reduction in cell contraction induced by LTD4 from
that observed in the presence of Ca21. On the contrary, hista-
mine-induced contraction was substantially reduced (by more
than 50%) in the absence of Ca21. This indicates that in iso-
lated HASM cells, the histamine response depends largely on
the presence of Ca21, whereas the LTD4 response is largely
Ca21-independent.
In seeking a Ca21-independent mechanism for LTD4-medi-
ated bronchoconstriction, we postulated an involvement of
PKC in LTD4-mediated signal transduction. Indeed, it is known
that: (1) LTD4 can activate PKC (7, 34); (2) LTD4-triggered
contraction in HB is rather slow, but is sustained in time; (3)
PKC is involved in the sustained phase of smooth-muscle con-
traction in general (35) and in HASM cells in particular (36,
37); and (4) HASM cells express different isoforms of PKC
(38), some of which (d, u, «, and h) are Ca21 independent.
Thus, using polyclonal antibodies against specific PKC iso-
forms (i.e., PKC-a) as representatives of the classical Ca21-
dependent isoforms of PKC, and against PKC-« as a represen-
tative of the Ca21-independent isoforms, we investigated their
activation. LTD4 was able to translocate PKC-« and, to a
lesser extent, PKC-a, whereas histamine was able to translo-
cate only PKC-a. The activation of PKC-« by LTD4 was con-
centration- and time-dependent. The decrease in PKC-« trans-
location at 15 and 30 min, with respect to 5 min, might suggest
a desensitization of the enzyme. This result is in agreement
with the tachyphylaxis displayed by LTD4 as a contractile agent
(39). Furthermore, inhibition of LTD4-induced translocation
of PKC by SKF 104353, a cysteinyl-LT1 antagonist, showed
that the activation was receptor-mediated.
To further link PKC activation and contraction of HB, we
evaluated the effect of PDBu, a PKC activator, on strips of
HB. PDBu was able to contract HB to the same extent in the
presence as in the absence of extra- and intracellular Ca21.
These data are apparently at variance with the previously re-
ported (37, 40) finding that removal of extracellular Ca21
abolished PDBu-induced HB contraction; however, the inves-
tigators who reported this generated cumulative concentra-
tion–response curves for PDBu, in which desensitization of
PKC yields a response lower than the one obtained by single-
dose administration, as also confirmed by Yang and Black
(40). In our hands, the slowly developing and sustained con-
traction of HB seemed to be Ca21-independent.
Interestingly, in the absence of Ca21, LTD4 was able to
contract HB to the same extent as was PDBu, thus suggesting
the involvement of a Ca21-independent PKC isoform in
LTD4-mediated signal transduction. This is confirmed by the
complete inhibition, in the absence of Ca21, of the LTD4 re-
sponse caused by PDBu-induced desensitization of PKC. In
addition, the PKC inhibitor H7 abolished the slow and sus-
tained contraction triggered by LTD4 in the absence of Ca
21.
The relatively minor effect of H7 on the response to LTD4 in
the presence of Ca21 suggests the involvement of mechanisms
other than PKC activation (possibly activation of myosin
light-chain kinase [41]) in the rapid phase of LTD4 contrac-
tion. Thus, the LTD4-induced response in HB consists of both
a Ca21-dependent phase (responsible for the onset of contrac-
tion) and a slower, Ca21-independent phase (responsible for
the maintenance of contractile tone). On the contrary, hista-
mine-induced contraction of HB is completely Ca21-dependent.
In conclusion, our data, taken collectively, indicate that in
human airways, LTD4-induced contraction is at least in part
independent of increases in Ca21, and this might represent an
extreme form of the increase in Ca21 sensitivity induced by ag-
onists (19). Such Ca21-independent contraction involves the
activation of one of the novel isoforms of PKC (i.e., PKC-«),
and indeed, PKC activation has been proposed as a mecha-
nism of increased force development at constant [Ca21]i (42).
The nature of the transduction pathway involved will be the
subject of future research. However, one can speculate that
Figure 7. Western blot analysis done with antibodies to PKC-a and
PKC-« on membrane proteins from HASM cells incubated with vehicle,
LTD4, or histamine. (A) Effect of LTD4 (0.3 mM) or histamine (100 mM)
on translocation of PKC-a to the membrane. (B) Effect of LTD4 (0.3 mM)
or histamine (100 mM) on translocation of PKC-«. (C) Time-course of
PKC-« translocation with 0.3 mM LTD4 (duplicate lanes are shown in
this case). (D) Effect of increasing concentrations of LTD4 on transloca-
tion of PKC-«. The last two lanes represent the effect of 10 mM SKF
104353 on translocation of PKC-« in cells stimulated with 0.3 mM LTD4
or in resting cells, respectively. Vehicle was MEM supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin, and 10 mM cysteine. In
(D) vehicle contained also 0.7% DMSO.
Figure 8. Western blot analysis done with antibodies to PKC-a and
PKC-« on membrane proteins from HASM cells incubated with 0.3 mM
LTD4 in the presence or absence of extracellular Ca
21. Effect of LTD4
on translocation of PKC-« (A) and PKC-a (B) in the presence (first two
lanes) and absence (last two lanes) of Ca21. Control samples contained
MEM supplemented with 100 U/ml penicillin, 100 mg/ml streptomy-
cin, and 10 mM cysteine.
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the LTD4 receptor is coupled to phospholipase D activation,
yielding diacylglycerol formation (and thus PKC activation)
without concomitant formation of Ca21. Additionally, our data
support the existence of a link between LTD4-induced activa-
tion of a Ca21-independent PKC and bronchial smooth-mus-
cle contraction. This pathway, which is specific for LTD4 (be-
ing abolished by two different receptor antagonists and not
shared by histamine), represents a novel transduction mecha-
nism for cysteinyl-LTs.
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